RxDoctor Payments Data

Seth Lessner, MD

Clinical Cardiac Electrophysiology · Middletown, NYNPI 1972761591

Payments from drug & device makers

$14,656in general payments, 2019–2025

Across 386 payments — averaging $37.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$6K
  • Medtronic$4K
  • Biosense Webster, Inc.$3K
  • Biotronik Inc.$389
  • Abbott$289
  • EBR Systems, Inc.$238
  • plus $641 from 12 others

What the payments were for

  • Travel & lodging$1,0717%
  • Food & beverage$13,58593%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$14,656 in reported general payments places this provider in the 35th percentile of 214 clinical cardiac electrophysiology providers in New York.

See all clinical cardiac electrophysiology providers in New York

Medicare billing

Part B allowed, 2024
$454,006
Medicare patients
1,117
Services billed
4,522

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban563$609,549
XareltoRivaroxaban139$149,373
MultaqDronedarone Hcl44$62,257
EntrestoSacubitril/Valsartan19$20,042
Dabigatran EtexilateDabigatran Etexilate Mesylate20$4,714
Amiodarone Hcl180$4,440
Dofetilide11$3,949
Metoprolol Succinate318$3,635
Atorvastatin Calcium100$956
Metoprolol Tartrate119$785
Diltiazem 24hr Er (Cd)Diltiazem Hcl40$736
Lisinopril105$664
Irbesartan13$571
Losartan Potassium60$458
Potassium Chloride42$422

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonXarelto$140$149,373139 claims
NovartisEntresto$21$20,04219 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 35th percentile of 214 clinical cardiac electrophysiology providers in New York.

Other clinical cardiac electrophysiology in Middletown

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →